{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:32:32Z","timestamp":1783128752292,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0738-z","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T08:39:11Z","timestamp":1450255151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models"],"prefix":"10.1186","volume":"13","author":[{"given":"Jackelyn B.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Diaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Debanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"key":"738_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"738_CR2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","volume":"58","author":"AB Kimball","year":"2008","unstructured":"Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG, National Psoriasis F. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58:1031\u201342.","journal-title":"J Am Acad Dermatol"},{"key":"738_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013;149:84\u201391.","journal-title":"JAMA Dermatol"},{"key":"738_CR4","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347:f5961.","journal-title":"BMJ"},{"key":"738_CR5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","volume":"68","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68:654\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"738_CR6","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","volume":"64","author":"RG Langley","year":"2005","unstructured":"Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(Suppl 2):ii18\u201323 (discussion ii24\u201315).","journal-title":"Ann Rheum Dis."},{"key":"738_CR7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2010.12","volume":"130","author":"JM Gelfand","year":"2010","unstructured":"Gelfand JM, Azfar RS, Mehta NN. Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol. 2010;130:919\u201322.","journal-title":"J Invest Dermatol"},{"key":"738_CR8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000\u20136.","journal-title":"Eur Heart J"},{"key":"738_CR9","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","volume":"129","author":"JM Gelfand","year":"2009","unstructured":"Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129:2411\u20138.","journal-title":"J Invest Dermatol"},{"key":"738_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cyto.2013.03.013","volume":"62","author":"JB Golden","year":"2013","unstructured":"Golden JB, McCormick TS, Ward NL. IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities. Cytokine. 2013;62:195\u2013201.","journal-title":"Cytokine"},{"key":"738_CR11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2014.08.008","volume":"127","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Kimball AB. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities. Am J Med. 2014;127:1148\u201353.","journal-title":"Am J Med"},{"key":"738_CR12","doi-asserted-by":"crossref","unstructured":"Ahlehoff O, Skov L, Gislason G, Gniadecki R, Iversen L, Bryld LE, Lasthein S, Lindhardsen J, Kristensen SL, Torp-Pedersen C, Hansen PR. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol. 2014;29:1128\u201334.","DOI":"10.1111\/jdv.12768"},{"key":"738_CR13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","volume":"190","author":"A Johnston","year":"2013","unstructured":"Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J Immunol. 2013;190:2252\u201362.","journal-title":"J Immunol"},{"key":"738_CR14","first-page":"805","volume":"11","author":"Y Bordon","year":"2011","unstructured":"Bordon Y. Cytokines: IL-17C joins the family firm. Nat Rev Immunol. 2011;11:805.","journal-title":"Nat Rev Immunol"},{"key":"738_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol. 2013;133:17\u201326.","journal-title":"J Invest Dermatol"},{"key":"738_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","volume":"160","author":"C Johansen","year":"2009","unstructured":"Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009;160:319\u201324.","journal-title":"Br J Dermatol"},{"key":"738_CR17","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/jid.2012.112","volume":"132","author":"Y Wang","year":"2012","unstructured":"Wang Y, Gao H, Loyd CM, Fu W, Diaconu D, Liu S, Cooper KD, McCormick TS, Simon DI, Ward NL. Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J Invest Dermatol. 2012;132:2067\u201375.","journal-title":"J Invest Dermatol"},{"key":"738_CR18","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.1402307","volume":"195","author":"JB Golden","year":"2015","unstructured":"Golden JB, Groft SG, Squeri MV, Debanne SM, Ward NL, McCormick TS, Cooper KD. Chronic psoriatic skin inflammation leads to increased monocyte adhesion and aggregation. J Immunol. 2015;195:2006\u201318.","journal-title":"J Immunol"},{"key":"738_CR19","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Fits van der","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol. 2009;182:5836\u201345.","journal-title":"J Immunol"},{"key":"738_CR20","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","volume":"111","author":"HL Ha","year":"2014","unstructured":"Ha HL, Wang H, Pisitkun P, Kim JC, Tassi I, Tang W, Morasso MI, Udey MC, Siebenlist U. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci USA. 2014;111:E3422\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"738_CR21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.biomaterials.2011.11.011","volume":"33","author":"PP Shah","year":"2012","unstructured":"Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33:1607\u201317.","journal-title":"Biomaterials"},{"key":"738_CR22","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI26987","volume":"115","author":"B Furie","year":"2005","unstructured":"Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest. 2005;115:3355\u201362.","journal-title":"J Clin Invest"},{"key":"738_CR23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2353\/ajpath.2009.080858","volume":"174","author":"JA Wolfram","year":"2009","unstructured":"Wolfram JA, Diaconu D, Hatala DA, Rastegar J, Knutsen DA, Lowther A, Askew D, Gilliam AC, McCormick TS, Ward NL. Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis. Am J Pathol. 2009;174:1443\u201358.","journal-title":"Am J Pathol"},{"key":"738_CR24","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI70966","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Fang C, Gao H, Bilodeau ML, Zhang Z, Croce K, Liu S, Morooka T, Sakuma M, Nakajima K, et al. Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J Clin Invest. 2014;124:2160\u201371.","journal-title":"J Clin Invest"},{"key":"738_CR25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/jth.12619","volume":"12","author":"MM Mumaw","year":"2014","unstructured":"Mumaw MM, de la Fuente M, Noble DN, Nieman MT. Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis. J Thromb Haemost. 2014;12:1331\u201341.","journal-title":"J Thromb Haemost"},{"key":"738_CR26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","volume":"34","author":"S Karbach","year":"2014","unstructured":"Karbach S, Croxford AL, Oelze M, Schuler R, Minwegen D, Wegner J, Koukes L, Yogev N, Nikolaev A, Reissig S, et al. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol. 2014;34:2658\u201368.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"738_CR27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735\u201341.","journal-title":"JAMA"},{"key":"738_CR28","doi-asserted-by":"crossref","unstructured":"Ahlehoff O, Gislason G, Lamberts M, Folke F, Lindhardsen J, Larsen CT, Torp-Pedersen C, Hansen PR. Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study. J Intern Med. 2014;277:447\u201355.","DOI":"10.1111\/joim.12272"},{"key":"738_CR29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/jid.2015.8","volume":"135","author":"M Koch","year":"2015","unstructured":"Koch M, Baurecht H, Ried JS, Rodriguez E, Schlesinger S, Volks N, Gieger C, Ruckert IM, Heinrich L, Willenborg C, et al. Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol. 2015;135:1283\u201393.","journal-title":"J Invest Dermatol"},{"key":"738_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G Liuzzo","year":"1994","unstructured":"Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417\u201324.","journal-title":"N Engl J Med"},{"key":"738_CR31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657\u201363.","journal-title":"Lancet"},{"key":"738_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3899\/jrheum.120621","volume":"40","author":"AG Semb","year":"2013","unstructured":"Semb AG, Rollefstad S, Provan SA, Kvien TK, Stranden E, Olsen IC, Hisdal J. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol. 2013;40:359\u201368.","journal-title":"J Rheumatol"},{"key":"738_CR33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2133.2011.10257.x","volume":"164","author":"K Reich","year":"2011","unstructured":"Reich K, Langley RG, Lebwohl M, Szapary P, Guzzo C, Yeilding N, Li S, Hsu MC, Griffiths CE. Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol. 2011;164:862\u201372.","journal-title":"Br J Dermatol"},{"key":"738_CR34","first-page":"899","volume":"12","author":"JJ Wu","year":"2013","unstructured":"Wu JJ, Poon KY, Bebchuk JD. Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. J Drugs Dermatol. 2013;12:899\u2013903.","journal-title":"J Drugs Dermatol"},{"key":"738_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","volume":"273","author":"O Ahlehoff","year":"2013","unstructured":"Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, Lasthein S, Gniadecki R, Dam TN, Torp-Pedersen C, Hansen PR. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med. 2013;273:197\u2013204.","journal-title":"J Intern Med"},{"key":"738_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12219","volume":"262","author":"P Dutta","year":"2014","unstructured":"Dutta P, Nahrendorf M. Regulation and consequences of monocytosis. Immunol Rev. 2014;262:167\u201378.","journal-title":"Immunol Rev"},{"key":"738_CR37","doi-asserted-by":"crossref","first-page":"e75500","DOI":"10.1371\/journal.pone.0075500","volume":"8","author":"E Jalbert","year":"2013","unstructured":"Jalbert E, Crawford TQ, D\u2019Antoni ML, Keating SM, Norris PJ, Nakamoto BK, Seto T, Parikh NI, Shikuma CM, Ndhlovu LC, Barbour JD. IL-1Beta enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease. PLoS One. 2013;8:e75500.","journal-title":"PLoS One"},{"key":"738_CR38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","volume":"68","author":"NT Funderburg","year":"2015","unstructured":"Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B, Clagett B, Robinson J, Lederman MM, McComsey GA. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;68:396\u2013404.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"738_CR39","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","volume":"54","author":"L Mallbris","year":"2006","unstructured":"Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"738_CR40","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.bbalip.2014.09.008","volume":"1841","author":"L He","year":"2014","unstructured":"He L, Qin S, Dang L, Song G, Yao S, Yang N, Li Y. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein. Biochim Biophys Acta. 2014;1841:1709\u201315.","journal-title":"Biochim Biophys Acta"},{"key":"738_CR41","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","volume":"15","author":"CM Steyers 3rd","year":"2014","unstructured":"Steyers CM 3rd, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15:11324\u201349.","journal-title":"Int J Mol Sci"},{"key":"738_CR42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874372200802010064","volume":"2","author":"L Mallbris","year":"2008","unstructured":"Mallbris L, Pernow J, Stahle M. Endothelial function and inflammatory activity in patients with recent onset of severe plaque psoriasis. Open Dermatol J. 2008;2:64\u20138.","journal-title":"Open Dermatol J"},{"key":"738_CR43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2013.10.023","volume":"232","author":"S Shaharyar","year":"2014","unstructured":"Shaharyar S, Warraich H, McEvoy JW, Oni E, Ali SS, Karim A, Jamal O, Blaha MJ, Blumenthal RS, Fialkow J, et al. Subclinical cardiovascular disease in plaque psoriasis: association or causal link? Atherosclerosis. 2014;232:72\u20138.","journal-title":"Atherosclerosis"},{"key":"738_CR44","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/exd.12551","volume":"23","author":"F Pelletier","year":"2014","unstructured":"Pelletier F, Garnache-Ottou F, Biichle S, Vivot A, Humbert P, Saas P, Seilles E, Aubin F. Effects of anti-TNF-alpha agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis. Exp Dermatol. 2014;23:924\u20135.","journal-title":"Exp Dermatol"},{"key":"738_CR45","doi-asserted-by":"crossref","unstructured":"Schmidt DE, Manca M, Hoefer IE. Circulating endothelial cells in coronary artery disease and acute coronary syndrome. Trends Cardiovasc Med. 2015;25:578\u201387.","DOI":"10.1016\/j.tcm.2015.01.013"},{"key":"738_CR46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","volume":"148","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Poon KY, Channual JC, Shen AY. Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. Arch Dermatol. 2012;148:1244\u201350.","journal-title":"Arch Dermatol"},{"key":"738_CR47","doi-asserted-by":"crossref","unstructured":"Naik HB, Natarajan B, Stansky E, Ahlman MA, Teague H, Salahuddin T, Ng Q, Joshi AA, Krishnamoorthy P, Dave J, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET\/CT and neutrophil activation in a prospective observational study. Arterioscler Thromb Vasc Biol. 2015. (Epub ahead of print)","DOI":"10.1161\/ATVBAHA.115.306460"},{"key":"738_CR48","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107:15880\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"738_CR49","doi-asserted-by":"crossref","unstructured":"Knight JS, Subramanian V, O\u2019Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann Rheum Dis. 2015;74(12):2199\u2013206.","DOI":"10.1136\/annrheumdis-2014-205365"},{"key":"738_CR50","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1172\/JCI67390","volume":"123","author":"JS Knight","year":"2013","unstructured":"Knight JS, Zhao W, Luo W, Subramanian V, O\u2019Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest. 2013;123:2981\u201393.","journal-title":"J Clin Invest"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0738-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T20:16:35Z","timestamp":1748722595000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0738-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"382"}}